Skip to content Outputs by Type Journal article
2024
Cancer-Therapy-Induced Cardiotoxicity: Results of the Analysis of the UK Yellow Card Adverse Drug Reaction (ADR) Reporting Stefanie Ho Yi Chan, Deborah Layton, sherael Webley and Sam Salek 2024. Cancer-Therapy-Induced Cardiotoxicity: Results of the Analysis of the UK Yellow Card Adverse Drug Reaction (ADR) Reporting. Cancers. 16 (24) 4223. https://doi.org/10.3390/cancers16244223
2023
Identification of cardiotoxicity related to non-small cell lung cancer (NSCLC) treatments: A systematic review Chan, S.H.Y., Yasmin Khatib, Sherael Webley, Deborah Layton and Sam Salek 2023. Identification of cardiotoxicity related to non-small cell lung cancer (NSCLC) treatments: A systematic review. Frontiers in Pharmacology. 14 1137983. https://doi.org/10.3389/fphar.2023.1137983
2023
Dry powder formulation of azithromycin for COVID-19 therapeutics Chan, S.H.Y., Sheikh, K., Zariwala, M. and Somavarapu, S. 2023. Dry powder formulation of azithromycin for COVID-19 therapeutics. Journal of Microencapsulation. 40 (4), pp. 217-232. https://doi.org/10.1080/02652048.2023.2175924
2023
Curcumin and N-Acetylcysteine Nanocarriers Alone or Combined with Deferoxamine Target the Mitochondria and Protect against Neurotoxicity and Oxidative Stress in a Co-Culture Model of Parkinson’s Disease Mursaleen, L., Chan, S.H.Y., Noble, B., Somavarapu, S. and Zariwala, M. 2023. Curcumin and N-Acetylcysteine Nanocarriers Alone or Combined with Deferoxamine Target the Mitochondria and Protect against Neurotoxicity and Oxidative Stress in a Co-Culture Model of Parkinson’s Disease. Antioxidants. 12 (1) 130. https://doi.org/10.3390/antiox12010130
2020
N-Acetylcysteine Nanocarriers Protect against Oxidative Stress in a Cellular Model of Parkinson’s Disease Mursaleen, L., Noble, B., Chan, S.H.Y., Somavarapu, S. and Zariwala, M. 2020. N-Acetylcysteine Nanocarriers Protect against Oxidative Stress in a Cellular Model of Parkinson’s Disease. Antioxidants. 9 (7) 600. https://doi.org/10.3390/antiox9070600
